Johnson & Johnson (JNJ)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 10:28AM EDT. Market open.
| Previous Close | 148.58 |
| Open | 149.38 |
| Bid | 149.49 x 1000 |
| Ask | 149.51 x 800 |
| Day's Range | 148.92 - 149.73 |
| 52 Week Range | 143.13 - 175.97 |
| Volume | |
| Avg. Volume | 7,631,908 |
| Market Cap | 360.247B |
| Beta (5Y Monthly) | 0.53 |
| PE Ratio (TTM) | 22.24 |
| EPS (TTM) | 6.73 |
| Earnings Date | Jul 17, 2024 |
| Forward Dividend & Yield | 4.96 (3.34%) |
| Ex-Dividend Date | May 20, 2024 |
| 1y Target Est | 160.79 |
Simply Wall St.With 71% ownership, Johnson & Johnson (NYSE:JNJ) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies Johnson & Johnson's stock price is sensitive to their...
GuruFocus.comBeyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
Insightful Analysis of Shockwave Medical's Position in the Cardiovascular Device Market
GlobeNewswireShockwave Medical Reports First Quarter 2024 Financial Results
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended March 31, 2024. “The solid growth in the first quarter across geographies and products is a testament to the continued demand for our innovative solutions, driven by the unrelenting and extraordinary performance of ou
© 2024 Yahoo. All rights reserved.